Changes in Hong Kong stocks | Jinhai Medical Technology (02225) rose more than 11% in early trading and was included in the Hang Seng Composite Index and is expected to enter Hong Kong Stock Connect later

The Zhitong Finance App learned that Jinhai Medical Technology (02225) rose by more than 11% in early trading. As of press release, it had risen 10.86% to HK$5.36, with a turnover of HK$11.217,700.

According to the news, Hang Seng Index announced the quarterly review results. Changes to the Hang Seng Composite Index will be implemented after the market closes on September 4 (Friday) and will take effect on September 7 (Monday). Among them, Jinhai Medical Technology was included in the Hang Seng Composite Index, and may later be transferred to the Hong Kong Stock Connect because it has met a series of standards including market value and liquidity.

On August 3, Jinhai Medical Technology issued an announcement announcing the appointment of Mr. Ma Chengdong as the Group's Chief Marketing Officer, effective from August 3, 2026, for an initial term of one year. According to the announcement, Ma Chengdong will be mainly responsible for the marketing strategy, market access, academic promotion, sales and channel operation of the Group's products, and supervise the commercialization of the Group's medical devices and equipment products.